Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Harvard Business School
AstraZeneca
Merck
Colorcon
Queensland Health
Cantor Fitzgerald
QuintilesIMS

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DISULFIRAM

« Back to Dashboard

Clinical Trials for Disulfiram

Trial ID Title Status Sponsor Phase Summary
NCT00000278 Disulfiram for Cocaine-Alcohol Abuse - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00000278 Disulfiram for Cocaine-Alcohol Abuse - 3 Completed VA Connecticut Healthcare System Phase 2 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00000278 Disulfiram for Cocaine-Alcohol Abuse - 3 Completed Yale University Phase 2 The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.
NCT00002065 Depot Disulfiram for AIDS and ARC Completed St. Vincent's Medical Center N/A To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Disulfiram

Condition Name

Condition Name for Disulfiram
Intervention Trials
Alcohol Dependence 5
Cocaine-Related Disorders 4
Alcoholism 4
Cocaine Dependence 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Disulfiram
Intervention Trials
Alcoholism 12
Cocaine-Related Disorders 11
Glioblastoma 7
Disease 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Disulfiram

Trials by Country

Trials by Country for Disulfiram
Location Trials
United States 42
Canada 2
Australia 2
Greece 1
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Disulfiram
Location Trials
California 7
Connecticut 6
New York 4
Missouri 3
Arkansas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Disulfiram

Clinical Trial Phase

Clinical Trial Phase for Disulfiram
Clinical Trial Phase Trials
Phase 4 8
Phase 3 1
Phase 2/Phase 3 3
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Disulfiram
Clinical Trial Phase Trials
Completed 29
Recruiting 9
Not yet recruiting 5
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Disulfiram

Sponsor Name

Sponsor Name for Disulfiram
Sponsor Trials
National Institute on Drug Abuse (NIDA) 10
Yale University 8
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 5
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Disulfiram
Sponsor Trials
Other 70
NIH 17
U.S. Fed 4
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
QuintilesIMS
Fish and Richardson
US Department of Justice
Queensland Health
McKinsey
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.